Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page. This update does not affect the study details, eligibility, or other user-facing content.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated to v3.4.3 on 2026-03-12 with new entries (126, 2026-03-11, 2026-03-09). The previous revision v3.4.2 (2026-02-14, 2025-07-25, 130) has been superseded.SummaryDifference0.3%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedEnrollment updated to 130 (from 126). The latest update dates are Last Update Posted on 2026-02-17 and Last Update Submitted on 2026-02-14, with earlier dates removed.SummaryDifference0.2%

- Check49 days agoChange DetectedRevision: v3.4.2 is now displayed; the notice about government funding lapse and the Revision: v3.4.1 update have been removed.SummaryDifference0.3%

- Check57 days agoChange DetectedA site-wide notice about a lapse in government funding and ongoing open status was added, and the page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page now shows a new 'Show glossary' option, the 'Last Update Submitted that Met QC Criteria' timestamp, and a new 'Revision: v3.4.0'. Capitalization tweaks to 'No FEAR Act Data' appear, and references to 'No FEAR Act data' and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.